RH Belmaker, G Agam - New England Journal of Medicine, 2008 - Mass Medical Soc
This review of major depressive disorder is a comprehensive account of the genetic, biochemical, and neurophysiological changes that have been implicated in the disorder. No …
Y Feng, X He, Y Yang, D Chao… - Current drug …, 2012 - ingentaconnect.com
The use of opioid analgesics has a long history in clinical settings, although the comprehensive action of opioid receptors is still less understood. Nonetheless, recent …
Opioid receptors are widely distributed throughout the brain and play an essential role in modulating aspects of human mood, reward, and well-being. Accumulating evidence …
Compared to the better-known mu opioid receptor, delta opioid receptors have been relatively understudied. However, the development of highly selective delta opioid agonists …
Decades of research advances have established a central role for endogenous opioid systems in regulating reward processing, mood, motivation, learning and memory …
Depression is a debilitating chronic illness that affects around 350 million people worldwide. Current treatments, such as selective serotonin reuptake inhibitors, are not ideal because …
Evidence that the delta opioid receptor (DOR) is an attractive target for the treatment of brain disorders has strengthened in recent years. This receptor is broadly expressed in the brain …
CM Cahill, SV Holdridge, A Morinville - Trends in pharmacological …, 2007 - cell.com
A cell can regulate how it interacts with its external environment by controlling the number of plasma membrane receptors that are accessible for ligand stimulation. G-protein-coupled …
CA Browne, I Lucki - Pharmacology & therapeutics, 2019 - Elsevier
Since the serendipitous discovery of the first class of modern antidepressants in the 1950's, all pharmacotherapies approved by the Food and Drug Administration for major depressive …